arrow
A

Annunziata Dattola

sapienza university of rone
H指数:23
被引数:1,734

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeted Therapy for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Critical Narrative Review and an Evidence-Graded Approach to Agent Selection

靶向治疗用于抗组胺药难治性慢性自发性荨麻疹:一项批判性叙事综述及基于证据等级的药物选择方法

2026-09-180
OA
Patient-Level Cumulative Clinical Benefit of Brodalumab Over 52 Weeks: A Multicentre Real-World Study-IL PSO (Italian Landscape Psoriasis)

52周内布达拉木单抗在患者层面的累积临床获益:一项多中心真实世界研究-IL PSO(意大利银屑病全景)

2026-09-170
OAAI
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study

非节段性白癜风患者外用鲁索利替尼的实世界有效性:一项860例患者多中心研究中关于复色、心理健康和生活质量结局的研究

2026-08-170
PRE
Trichoscopic Markers and Clinical Response Patterns With Ritlecitinib in Severe Alopecia Areata: 24-Week Outcomes From a Prospective Real-World Cohort

Ritlecitinib治疗严重斑秃的毛发镜标志物和临床应答模式:一项前瞻性真实世界队列24周研究结果

2026-04-240
OAAI
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort Study

中重度 Hidradenitis suppurativa 患者 Secukinumab 的长期疗效:一项多中心队列研究

2026-03-170
PRE
Combined Laser Strategies for Scar Treatment: A Comprehensive Review of Synergistic Protocols

Clementi, A.; Cannarozzo, G.; Guarino, L.; Zappia, E.; Cassalia, F.; Danese, A.; Gratteri, M.; Dattola, A.; Longo, C.; Nisticò, S.P. 激光联合策略在瘢痕治疗中的应用:协同方案的全面综述。Bioengineering 2025, 12, 1368. [Google Scholar] [CrossRef]

2026-03-040
OAAI
Dupilumab as a Therapeutic Option in Autoimmune Bullous Diseases Following SARS-CoV-2 Infection and COVID-19 Vaccination: A Comprehensive Case Series Analysis

Dupilumab作为SARS-CoV-2感染和COVID-19疫苗接种后自身免疫性大疱性疾病的治疗选择:一项全面的病例系列分析

2025-10-120
OAAI
Long-Term Persistence with Guselkumab: A 5-Year Multicenter Retrospective Study across 14 Dermatology Centers in Italy

guselkumab的长期持续性:一项在意大利14个皮肤病学中心进行的为期5年的多中心回顾性研究

2025-10-010
OAAI
Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms

中重度银屑病患者早期肌肉骨骼症状中IL-23抑制剂的真实世界分析

2025-09-080
OA
Super Responder Profile Under Bimekizumab Treatment in Moderate-to-Severe Psoriasis: A Short Term Real-Life Observation-IL PSO (Italian Landscape Psoriasis)

度普利尤单抗治疗中重度银屑病的强应答者特征:一项短期真实世界观察-IL PSO(意大利银屑病全景研究)

2025-05-150
OAAI